/

Imunologia e Infecção

/

Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter

JoVE Journal
Imunologia e Infecção

É necessária uma assinatura da JoVE para visualizar este conteúdo. Faça login ou comece sua avaliação gratuita.

JoVE Journal Imunologia e Infecção

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter

Please note that all translations are automatically generated. Click here for the English version.

Nachweis eines SARS-CoV-2-Rezeptor-bindenden Domänenantikörpers mit einem HiBiT-basierten Bioreporter

2,901 Views

•

07:44 min

•

August 12, 2021

DOI:

10.3791/62488-v

DOI:

10.3791/62488-v

•

07:44 min

August 12, 2021

•

14 Views

Reza Rezaei², Abera Surendran², Ragunath Singaravelu², Taylor R. Jamieson², Parisa Taklifi, Joanna Poutou², Taha Azad², Carolina S. Ilkow²

¹Ottawa Hospital Research Institute, ²Department of Biochemistry, Microbiology and Immunology,University of Ottawa, ³Department of Biotechnology,University of Tehran

Tags

SARS-CoV-2 Receptor-binding Domain Antibody Detection HiBiT-based Bioreporter COVID-19 Research High-throughput Assay Cell Culture Transfection Passive Lysis Buffer

Read Article